Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease

INTRODUCTION: Alzheimer's disease (AD) is associated with synapse loss. Souvenaid, containing the specific nutrient combination Fortasyn Connect, was designed to improve synapse formation and function. The NL-ENIGMA study explored the effect of Souvenaid on synapse function in early AD by asses...

詳細記述

保存先:
書誌詳細
出版年:Alzheimers Dement (N Y)
主要な著者: Scheltens, Nienke M.E., Briels, Casper T., Yaqub, Maqsood, Barkhof, Frederik, Boellaard, Ronald, van der Flier, Wiesje M., Schwarte, Lothar A., Teunissen, Charlotte E., Attali, Amos, Broersen, Laus M., van Berckel, Bart N.M., Scheltens, Philip
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier 2019
主題:
Featured Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6804721/
https://ncbi.nlm.nih.gov/pubmed/31650005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2019.08.002
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料